Cagrilintide trials for Obesity

All Cagrilintide trials · All Obesity trials

Phase breakdown

Recruiting trials studying Cagrilintide for Obesity

• A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
  NCT07557953 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
  NCT07253285 · Phase: Phase 3 · Ages: 8 Years to 18 Years · Sex: All (male and female) · 121 locations
• A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
  NCT07411560 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: Female · 1 location
• Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
  NCT07607587 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
  NCT07010432 · Phase: Phase 1 · Ages: 50 Years to 70 Years · Sex: Female · 1 location
• Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
  NCT07527195 · Phase: Phase 1 · Ages: 50 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Cagrilintide for Obesity?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.